SCOPUS 정보 검색 플랫폼

Volumn 430, Issue 2, 2012, Pages 171-178

Real-time quantification of antibody-short interfering RNA conjugate in serum by antigen capture reverse transcription-polymerase chain reaction

(11) Tan, Martha a Vernes, Jean Michel a Chan, Joyce a Cuellar, Trinna L a Asundi, Aarati a Nelson, Christopher a Yip, Victor a Shen, Ben a Vandlen, Richard a Siebel, Christian a Meng, Y Gloria a

a GENENTECH INC (United States)

Author keywords

Antibody; Antibody siRNA conjugate; Antigen capture; Assay; Real time PCR; RT PCR; siRNA

Indexed keywords

ANTIBODIES; ANTIGENS; ASSAYS; CELL MEMBRANES; MAMMALS; PHARMACOKINETICS; RNA;

PHARMACOKINETIC ANALYSIS; REAL-TIME PCR; REAL-TIME QUANTIFICATION; REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION; RT-PCR; SHORT INTERFERING RNA (SIRNA); SIRNA; THERAPEUTIC POTENTIALS;

POLYMERASE CHAIN REACTION;

ANTIGEN; RNA ANTIBODY; SMALL INTERFERING RNA; STREPTAVIDIN;

ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA DEGRADATION;

MUS;

EID: 84866640056 PISSN: 00032697 EISSN: 10960309 Source Type: Journal
DOI: 10.1016/j.ab.2012.08.018 Document Type: Article

Times cited : (14)

References (28)

1
- 0032545933
- Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
- A. Fire, S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver, and C.C. Mello Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 1998 806 811
- (1998) Nature , vol.391 , pp. 806-811
- Fire, A.¹ Xu, S.² Montgomery, M.K.³ Kostas, S.A.⁴ Driver, S.E.⁵ Mello, C.C.⁶

2
- 0035942736
- Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
- S.M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411 2001 494 498
- (2001) Nature , vol.411 , pp. 494-498
- Elbashir, S.M.¹ Harborth, J.² Lendeckel, W.³ Yalcin, A.⁴ Weber, K.⁵ Tuschl, T.⁶

3
- 0037019339
- RNA interference in adult mice
- A.P. McCaffrey, L. Meuse, T.T. Pham, D.S. Conklin, G.J. Hannon, and M.A. Kay RNA interference in adult mice Nature 418 2002 38 39
- (2002) Nature , vol.418 , pp. 38-39
- McCaffrey, A.P.¹ Meuse, L.² Pham, T.T.³ Conklin, D.S.⁴ Hannon, G.J.⁵ Kay, M.A.⁶

4
- 70349295861
- RNA interference technologies and therapeutics: From basic research to products
- M. Lopez-Fraga, T. Martinez, and A. Jimenez RNA interference technologies and therapeutics: from basic research to products BioDrugs 23 2009 305 332
- (2009) BioDrugs , vol.23 , pp. 305-332
- Lopez-Fraga, M.¹ Martinez, T.² Jimenez, A.³

5
- 31044444460
- Inhibition of RNase A family enzymes prevents degradation and loss of silencing activity of siRNAs in serum
- J. Haupenthal, C. Baehr, S. Kiermayer, S. Zeuzem, and A. Piiper Inhibition of RNase A family enzymes prevents degradation and loss of silencing activity of siRNAs in serum Biochem. Pharmacol. 71 2006 702 710
- (2006) Biochem. Pharmacol. , vol.71 , pp. 702-710
- Haupenthal, J.¹ Baehr, C.² Kiermayer, S.³ Zeuzem, S.⁴ Piiper, A.⁵

6
- 13944261143
- Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA
- C.R. Allerson, N. Sioufi, R. Jarres, T.P. Prakash, N. Naik, A. Berdeja, L. Wanders, R.H. Griffey, E.E. Swayze, and B. Bhat Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA J. Med. Chem. 48 2005 901 904
- (2005) J. Med. Chem. , vol.48 , pp. 901-904
- Allerson, C.R.¹ Sioufi, N.² Jarres, R.³ Prakash, T.P.⁴ Naik, N.⁵ Berdeja, A.⁶ Wanders, L.⁷ Griffey, R.H.⁸ Swayze, E.E.⁹ Bhat, B.¹⁰

7
- 66349108231
- A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability, and low toxicity
- J.B. Bramsen, M.B. Laursen, A.F. Nielsen, T.B. Hansen, C. Bus, N. Langkjaer, B.R. Babu, T. Hojland, M. Abramov, A. Van Aerschot, D. Odadzic, R. Smicius, J. Haas, C. Andree, J. Barman, M. Wenska, P. Srivastava, C. Zhou, D. Honcharenko, S. Hess, E. Muller, G.V. Bobkov, S.N. Mikhailov, E. Fava, T.F. Meyer, J. Chattopadhyaya, M. Zerial, J.W. Engels, P. Herdewijn, J. Wengel, and J. Kjems A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability, and low toxicity Nucleic Acids Res. 37 2009 2867 2881
- (2009) Nucleic Acids Res. , vol.37 , pp. 2867-2881
- Bramsen, J.B.¹ Laursen, M.B.² Nielsen, A.F.³ Hansen, T.B.⁴ Bus, C.⁵ Langkjaer, N.⁶ Babu, B.R.⁷ Hojland, T.⁸ Abramov, M.⁹ Van Aerschot, A.¹⁰ Odadzic, D.¹¹ Smicius, R.¹² Haas, J.¹³ Andree, C.¹⁴ Barman, J.¹⁵ Wenska, M.¹⁶ Srivastava, P.¹⁷ Zhou, C.¹⁸ Honcharenko, D.¹⁹ Hess, S.²⁰ more..

8
- 83255185737
- Special delivery: Targeted therapy with small RNAs
- D. Peer, and J. Lieberman Special delivery: targeted therapy with small RNAs Gene Ther. 18 2011 1127 1133
- (2011) Gene Ther. , vol.18 , pp. 1127-1133
- Peer, D.¹ Lieberman, J.²

9
- 23444445660
- Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
- D.V. Morrissey, J.A. Lockridge, L. Shaw, K. Blanchard, K. Jensen, W. Breen, K. Hartsough, L. Machemer, S. Radka, V. Jadhav, N. Vaish, S. Zinnen, C. Vargeese, K. Bowman, C.S. Shaffer, L.B. Jeffs, A. Judge, I. MacLachlan, and B. Polisky Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs Nat. Biotechnol. 23 2005 1002 1007
- (2005) Nat. Biotechnol. , vol.23 , pp. 1002-1007
- Morrissey, D.V.¹ Lockridge, J.A.² Shaw, L.³ Blanchard, K.⁴ Jensen, K.⁵ Breen, W.⁶ Hartsough, K.⁷ MacHemer, L.⁸ Radka, S.⁹ Jadhav, V.¹⁰ Vaish, N.¹¹ Zinnen, S.¹² Vargeese, C.¹³ Bowman, K.¹⁴ Shaffer, C.S.¹⁵ Jeffs, L.B.¹⁶ Judge, A.¹⁷ MacLachlan, I.¹⁸ Polisky, B.¹⁹

10
- 76349111051
- Rational design of cationic lipids for siRNA delivery
- S.C. Semple, A. Akinc, J. Chen, A.P. Sandhu, B.L. Mui, C.K. Cho, D.W. Sah, D. Stebbing, E.J. Crosley, E. Yaworski, I.M. Hafez, J.R. Dorkin, J. Qin, K. Lam, K.G. Rajeev, K.F. Wong, L.B. Jeffs, L. Nechev, M.L. Eisenhardt, M. Jayaraman, M. Kazem, M.A. Maier, M. Srinivasulu, M.J. Weinstein, Q. Chen, R. Alvarez, S.A. Barros, S. De, S.K. Klimuk, T. Borland, V. Kosovrasti, W.L. Cantley, Y.K. Tam, M. Manoharan, M.A. Ciufolini, M.A. Tracy, A. de Fougerolles, I. MacLachlan, P.R. Cullis, T.D. Madden, and M.J. Hope Rational design of cationic lipids for siRNA delivery Nat. Biotechnol. 28 2009 172 176
- (2009) Nat. Biotechnol. , vol.28 , pp. 172-176
- Semple, S.C.¹ Akinc, A.² Chen, J.³ Sandhu, A.P.⁴ Mui, B.L.⁵ Cho, C.K.⁶ Sah, D.W.⁷ Stebbing, D.⁸ Crosley, E.J.⁹ Yaworski, E.¹⁰ Hafez, I.M.¹¹ Dorkin, J.R.¹² Qin, J.¹³ Lam, K.¹⁴ Rajeev, K.G.¹⁵ Wong, K.F.¹⁶ Jeffs, L.B.¹⁷ Nechev, L.¹⁸ Eisenhardt, M.L.¹⁹ Jayaraman, M.²⁰ more..

11
- 67649408951
- SiRNA delivery using peptide transduction domains
- A. Eguchi, and S.F. Dowdy SiRNA delivery using peptide transduction domains Trends Pharmacol. Sci. 30 2009 341 345
- (2009) Trends Pharmacol. Sci. , vol.30 , pp. 341-345
- Eguchi, A.¹ Dowdy, S.F.²

12
- 41449109039
- Breathing life into polycations: Functionalization with pH-responsive endosomolytic peptides and polyethylene glycol enables siRNA delivery
- M. Meyer, A. Philipp, R. Oskuee, C. Schmidt, and E. Wagner Breathing life into polycations: functionalization with pH-responsive endosomolytic peptides and polyethylene glycol enables siRNA delivery J. Am. Chem. Soc. 130 2008 3272 3273
- (2008) J. Am. Chem. Soc. , vol.130 , pp. 3272-3273
- Meyer, M.¹ Philipp, A.² Oskuee, R.³ Schmidt, C.⁴ Wagner, E.⁵

13
- 79952092706
- Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy
- H.A. Burris III, H.S. Rugo, S.J. Vukelja, C.L. Vogel, R.A. Borson, S. Limentani, E. Tan-Chiu, I.E. Krop, R.A. Michaelson, S. Girish, L. Amler, M. Zheng, Y.W. Chu, B. Klencke, and J.A. O'Shaughnessy Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy J. Clin. Oncol. 29 2011 398 405
- (2011) J. Clin. Oncol. , vol.29 , pp. 398-405
- Burris Iii, H.A.¹ Rugo, H.S.² Vukelja, S.J.³ Vogel, C.L.⁴ Borson, R.A.⁵ Limentani, S.⁶ Tan-Chiu, E.⁷ Krop, I.E.⁸ Michaelson, R.A.⁹ Girish, S.¹⁰ Amler, L.¹¹ Zheng, M.¹² Chu, Y.W.¹³ Klencke, B.¹⁴ O'Shaughnessy, J.A.¹⁵

14
- 35848935409
- Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology
- C.F. Xia, Y. Zhang, R.J. Boado, and W.M. Pardridge Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology Pharm. Res. 24 2007 2309 2316
- (2007) Pharm. Res. , vol.24 , pp. 2309-2316
- Xia, C.F.¹ Zhang, Y.² Boado, R.J.³ Pardridge, W.M.⁴

15
- 23844474160
- Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
- E. Song, P. Zhu, S.K. Lee, D. Chowdhury, S. Kussman, D.M. Dykxhoorn, Y. Feng, D. Palliser, D.B. Weiner, P. Shankar, W.A. Marasco, and J. Lieberman Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors Nat. Biotechnol. 23 2005 709 717
- (2005) Nat. Biotechnol. , vol.23 , pp. 709-717
- Song, E.¹ Zhu, P.² Lee, S.K.³ Chowdhury, D.⁴ Kussman, S.⁵ Dykxhoorn, D.M.⁶ Feng, Y.⁷ Palliser, D.⁸ Weiner, D.B.⁹ Shankar, P.¹⁰ Marasco, W.A.¹¹ Lieberman, J.¹²

16
- 84860211700
- + breast cancer growth and metastasis
- + breast cancer growth and metastasis Sci. Transl. Med. 4 2012 130ra48
- (2012) Sci. Transl. Med. , vol.4
- Yao, Y.D.¹ Sun, T.M.² Huang, S.Y.³ Dou, S.⁴ Lin, L.⁵ Chen, J.N.⁶ Ruan, J.B.⁷ Mao, C.Q.⁸ Yu, F.Y.⁹ Zeng, M.S.¹⁰ Zang, J.Y.¹¹ Liu, Q.¹² Su, F.X.¹³ Zhang, P.¹⁴ Lieberman, J.¹⁵ Wang, J.¹⁶ Song, E.¹⁷

17
- 74449085757
- Lyophilized HER2-specific PEGylated immunoliposomes for active siRNA gene silencing
- J. Gao, J. Sun, H. Li, W. Liu, Y. Zhang, B. Li, W. Qian, H. Wang, J. Chen, and Y. Guo Lyophilized HER2-specific PEGylated immunoliposomes for active siRNA gene silencing Biomaterials 31 2009 2655 2664
- (2009) Biomaterials , vol.31 , pp. 2655-2664
- Gao, J.¹ Sun, J.² Li, H.³ Liu, W.⁴ Zhang, Y.⁵ Li, B.⁶ Qian, W.⁷ Wang, H.⁸ Chen, J.⁹ Guo, Y.¹⁰

18
- 34547131841
- Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma
- A.G. Polson, S.F. Yu, K. Elkins, B. Zheng, S. Clark, G.S. Ingle, D.S. Slaga, L. Giere, C. Du, C. Tan, J.A. Hongo, A. Gogineni, M.J. Cole, R. Vandlen, J.P. Stephan, J. Young, W. Chang, S.J. Scales, S. Ross, D. Eaton, and A. Ebens Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma Blood 110 2007 616 623
- (2007) Blood , vol.110 , pp. 616-623
- Polson, A.G.¹ Yu, S.F.² Elkins, K.³ Zheng, B.⁴ Clark, S.⁵ Ingle, G.S.⁶ Slaga, D.S.⁷ Giere, L.⁸ Du, C.⁹ Tan, C.¹⁰ Hongo, J.A.¹¹ Gogineni, A.¹² Cole, M.J.¹³ Vandlen, R.¹⁴ Stephan, J.P.¹⁵ Young, J.¹⁶ Chang, W.¹⁷ Scales, S.J.¹⁸ Ross, S.¹⁹ Eaton, D.²⁰ Ebens, A.²¹ more..

19
- 79955721463
- TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including glioma
- K. Lin, J.R. Taylor Jr., T.D. Wu, J. Gutierrez, J.M. Elliott, J.M. Vernes, H. Koeppen, H.S. Phillips, F.J. de Sauvage, and Y.G. Meng TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including glioma PLoS One 6 2011 e18608
- (2011) PLoS One , vol.6 , pp. 18608
- Lin, K.¹ Taylor, Jr.J.R.² Wu, T.D.³ Gutierrez, J.⁴ Elliott, J.M.⁵ Vernes, J.M.⁶ Koeppen, H.⁷ Phillips, H.S.⁸ De Sauvage, F.J.⁹ Meng, Y.G.¹⁰

20
- 29144470346
- Real-time quantification of microRNAs by stem-loop RT-PCR
- C. Chen, D.A. Ridzon, A.J. Broomer, Z. Zhou, D.H. Lee, J.T. Nguyen, M. Barbisin, N.L. Xu, V.R. Mahuvakar, M.R. Andersen, K.Q. Lao, K.J. Livak, and K.J. Guegler Real-time quantification of microRNAs by stem-loop RT-PCR Nucleic Acids Res. 33 2005 e179
- (2005) Nucleic Acids Res. , vol.33 , pp. 179
- Chen, C.¹ Ridzon, D.A.² Broomer, A.J.³ Zhou, Z.⁴ Lee, D.H.⁵ Nguyen, J.T.⁶ Barbisin, M.⁷ Xu, N.L.⁸ Mahuvakar, V.R.⁹ Andersen, M.R.¹⁰ Lao, K.Q.¹¹ Livak, K.J.¹² Guegler, K.J.¹³

21
- 49449087300
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- J.R. Junutula, H. Raab, S. Clark, S. Bhakta, D.D. Leipold, S. Weir, Y. Chen, M. Simpson, S.P. Tsai, M.S. Dennis, Y. Lu, Y.G. Meng, C. Ng, J. Yang, C.C. Lee, E. Duenas, J. Gorrell, V. Katta, A. Kim, K. McDorman, K. Flagella, R. Venook, S. Ross, S.D. Spencer, W.L. Wong, H.B. Lowman, R. Vandlen, M.X. Sliwkowski, R.H. Scheller, P. Polakis, and W. Mallet Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index Nat. Biotechnol. 26 2008 925 932
- (2008) Nat. Biotechnol. , vol.26 , pp. 925-932
- Junutula, J.R.¹ Raab, H.² Clark, S.³ Bhakta, S.⁴ Leipold, D.D.⁵ Weir, S.⁶ Chen, Y.⁷ Simpson, M.⁸ Tsai, S.P.⁹ Dennis, M.S.¹⁰ Lu, Y.¹¹ Meng, Y.G.¹² Ng, C.¹³ Yang, J.¹⁴ Lee, C.C.¹⁵ Duenas, E.¹⁶ Gorrell, J.¹⁷ Katta, V.¹⁸ Kim, A.¹⁹ McDorman, K.²⁰ more..

22
- 79955022475
- Disulfide-linked antibody-maytansinoid conjugates: Optimization of in vivo activity by varying the steric hindrance at carbon atoms adjacent to the disulfide linkage
- B.A. Kellogg, L. Garrett, Y. Kovtun, K.C. Lai, B. Leece, M. Miller, G. Payne, R. Steeves, K.R. Whiteman, W. Widdison, H. Xie, R. Singh, R.V. Chari, J.M. Lambert, and R.J. Lutz Disulfide-linked antibody-maytansinoid conjugates: optimization of in vivo activity by varying the steric hindrance at carbon atoms adjacent to the disulfide linkage Bioconjug. Chem. 22 2011 717 727
- (2011) Bioconjug. Chem. , vol.22 , pp. 717-727
- Kellogg, B.A.¹ Garrett, L.² Kovtun, Y.³ Lai, K.C.⁴ Leece, B.⁵ Miller, M.⁶ Payne, G.⁷ Steeves, R.⁸ Whiteman, K.R.⁹ Widdison, W.¹⁰ Xie, H.¹¹ Singh, R.¹² Chari, R.V.¹³ Lambert, J.M.¹⁴ Lutz, R.J.¹⁵

23
- 30344456035
- Facile means for quantifying microRNA expression by real-time PCR
- R. Shi, and V.L. Chiang Facile means for quantifying microRNA expression by real-time PCR BioTechniques 39 2005 519 525
- (2005) BioTechniques , vol.39 , pp. 519-525
- Shi, R.¹ Chiang, V.L.²

24
- 46549083921
- Examination of real-time polymerase chain reaction methods for the detection and quantification of modified siRNA
- S. Stratford, S. Stec, V. Jadhav, J. Seitzer, M. Abrams, and M. Beverly Examination of real-time polymerase chain reaction methods for the detection and quantification of modified siRNA Anal. Biochem. 379 2008 96 104
- (2008) Anal. Biochem. , vol.379 , pp. 96-104
- Stratford, S.¹ Stec, S.² Jadhav, V.³ Seitzer, J.⁴ Abrams, M.⁵ Beverly, M.⁶

25
- 79952609669
- In vivo quantification of formulated and chemically modified small interfering RNA by heating-in-Triton quantitative reverse transcription polymerase chain reaction (HIT qRT-PCR)
- Y. Landesman, N. Svrzikapa, A. Cognetta III, X. Zhang, B.R. Bettencourt, S. Kuchimanchi, K. Dufault, S. Shaikh, M. Gioia, A. Akinc, R. Hutabarat, and R. Meyers In vivo quantification of formulated and chemically modified small interfering RNA by heating-in-Triton quantitative reverse transcription polymerase chain reaction (HIT qRT-PCR) Silence 1 2010 16
- (2010) Silence , vol.1 , pp. 16
- Landesman, Y.¹ Svrzikapa, N.² Cognetta Iii, A.³ Zhang, X.⁴ Bettencourt, B.R.⁵ Kuchimanchi, S.⁶ Dufault, K.⁷ Shaikh, S.⁸ Gioia, M.⁹ Akinc, A.¹⁰ Hutabarat, R.¹¹ Meyers, R.¹²

26
- 0035803583
- Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate
- S.M. Elbashir, J. Martinez, A. Patkaniowska, W. Lendeckel, and T. Tuschl Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate EMBO J. 20 2001 6877 6888
- (2001) EMBO J. , vol.20 , pp. 6877-6888
- Elbashir, S.M.¹ Martinez, J.² Patkaniowska, A.³ Lendeckel, W.⁴ Tuschl, T.⁵

27
- 56449129810
- Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate
- G.D. Lewis Phillips, G. Li, D.L. Dugger, L.M. Crocker, K.L. Parsons, E. Mai, W.A. Blattler, J.M. Lambert, R.V. Chari, R.J. Lutz, W.L. Wong, F.S. Jacobson, H. Koeppen, R.H. Schwall, S.R. Kenkare-Mitra, S.D. Spencer, and M.X. Sliwkowski Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate Cancer Res. 68 2008 9280 9290
- (2008) Cancer Res. , vol.68 , pp. 9280-9290
- Lewis Phillips, G.D.¹ Li, G.² Dugger, D.L.³ Crocker, L.M.⁴ Parsons, K.L.⁵ Mai, E.⁶ Blattler, W.A.⁷ Lambert, J.M.⁸ Chari, R.V.⁹ Lutz, R.J.¹⁰ Wong, W.L.¹¹ Jacobson, F.S.¹² Koeppen, H.¹³ Schwall, R.H.¹⁴ Kenkare-Mitra, S.R.¹⁵ Spencer, S.D.¹⁶ Sliwkowski, M.X.¹⁷

28
- 33745128099
- Aptamer mediated siRNA delivery
- T.C. Chu, K.Y. Twu, A.D. Ellington, and M. Levy Aptamer mediated siRNA delivery Nucleic Acids Res. 34 2006 e73
- (2006) Nucleic Acids Res. , vol.34 , pp. 73
- Chu, T.C.¹ Twu, K.Y.² Ellington, A.D.³ Levy, M.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.